INTS3 and NABP interacting protein pseudogene

INTS3 and NABP interacting protein pseudogene (ENSG00000282855) is classified as a pseudogene—a segment of DNA that resembles a functional gene but has accumulated mutations that prevent it from encoding a functional protein[1][3]. Pseudogenes generally originate from duplication or retrotransposition events and lose protein-coding capacity due to mutations[3][5]. While most pseudogenes are not translated into functional proteins, some can be transcribed and are implicated in the regulation of gene expression, either as sources of noncoding RNAs or by acting as microRNA decoys[3][5]. However, there is no evidence indicating this specific pseudogene is actively transcribed, translated, or involved in disease, nor is it a recognized therapeutic target. Key points specific to this entry: - Not a protein, receptor, or drug target: It is a DNA locus without an encoded functional protein product[1][3]. - Not a standard gene symbol or abbreviation: The provided name is not one of the standardized nomenclature forms for therapeutic targets. - No known drugs or disease biomarkers: There are no known drugs or biomarkers associated with this pseudogene. Additional notes: - The main functional and clinical interest in pseudogenes like this comes from some examples where they affect gene regulation in select diseases, but this role remains unestablished and unstructured for ENSG00000282855[5]. - If any updated or alternate curation data emerges (e.g., expression in a disease context), these entries may need revision. This summary follows conventions for pseudogene annotation and recognizes that, unless future studies reveal functional activity, "INTS3 and NABP interacting protein pseudogene" is not a direct molecular target for therapy or a validated biomarker[3][5][1].

Other names

INTS3 and NABP interacting protein (INIP) pseudogene